
David S. Hong MD
@davidhongmd
MD Anderson Cancer Center medical oncologist, Deputy Chair of Dept. Investigational Cancer Therapeutics. Phase I clinical trials.Tweets are mine.
ID: 4912387590
http://faculty.mdanderson.org/david_hong/ 15-02-2016 19:06:23
2,2K Tweet
3,3K Takipçi
957 Takip Edilen




Sanjay if you start a show I will be your first guest! Sanjay Popat funniest man in Oncology!





Familiar face on Houston’s highways 🛣️ Katy Rezvani, M.D., Ph.D MD Anderson Cancer Center



The Legend Razelle Kurzrock, MD !



Congrats to Dr Tara Davidson, and Dr Derrick Tao and missing in this picture Dr Kunwha Kim for finishing your Med Onc fellowship at MD Anderson Cancer Center! It was an honor to have mentored you all! God Speed and God Bless! I look forward to your success!


In a interview, David S. Hong MD detailed: ⭐️ The implications of the full FDA approval of larotrectinib ⭐️ His experience administering the agent to patients ⭐️ The importance of testing patients for alterations such as NTRK fusions Read more: hubs.li/Q03rltJ-0



